Ademi LLP is investigating Atlas (Nasdaq: ATCX) for possible breaches of fiduciary duty and other violations of law in its transaction with GI Partners.
Ademi LLP alleges Atlas’s financial outlook and prospects are excellent and yet Atlas shareholders will receive only $12.25 per share in an all-cash transaction valued at approximately $1.05 billion, including outstanding debt. The transaction agreement unreasonably limits competing bids for Atlas by imposing a significant penalty if Atlas accepts a superior bid. Atlas insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of Atlas’s board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Atlas.